project id: TCGA-KIRC; case submitter id: TCGA-CW-6096; aliquot quantity: 40.0; aliquot volume: 80.0; concentration: 0.5; source center: 22; state: released; analyte type: Repli-G (Qiagen) DNA; analyte type id: W; experimental protocol type: Repli-G; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 44; days to birth: -16140; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 16140; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2701.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8310/3; primary diagnosis: Clear cell adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; longest dimension: 1.0; preservation method: Unknown; specimen type: Solid Tissue; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 85.0;